Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure

33Citations
Citations of this article
61Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Liver failure is a severe clinical syndrome with a poor prognosis. Mesenchymal stem cell (MSC) transplantation has emerged as a new intervention in treating liver failure. It is conventionally recognized that MSCs exert their therapeutic effect mainly through transdifferentiation. Recently, published articles have shown that MSCs work in liver failure by secreting trophic and immunomodulatory factors as well as extracellular vesicles (EVs) before transdifferentiation. In particular,MSC-derived EVs have shown similar curative effects as MSCs. Here we review the role of MSCs as well as their derived factors and EVs in liver failure and discuss the use of MSC-derived EVs instead of intact MSCs in treating liver failure.

Cite

CITATION STYLE

APA

Wang, J., Cen, P., Chen, J., Fan, L., Li, J., Cao, H., & Li, L. (2017, June 6). Role of mesenchymal stem cells, their derived factors, and extracellular vesicles in liver failure. Stem Cell Research and Therapy. BioMed Central Ltd. https://doi.org/10.1186/s13287-017-0576-4

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free